Eleven Therapeutics Announced Research Collaboration with Novo Nordisk to Discover Cell-Specific Carriers of Nucleic Acid Therapeutics
Portfolio Pulse from Charles Gross
Biotechnology company Eleven Therapeutics has announced a research collaboration with global healthcare company Novo Nordisk. The collaboration aims to identify novel molecules for precise delivery of nucleic acid using Eleven's DELiveri™ platform, targeting cardiometabolic diseases.
July 17, 2023 | 9:26 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Novo Nordisk is entering a research collaboration with Eleven Therapeutics to discover novel molecules for precise delivery of nucleic acid. This could potentially lead to advancements in treatment for cardiometabolic diseases.
The collaboration with Eleven Therapeutics could potentially lead to advancements in Novo Nordisk's treatment options for cardiometabolic diseases. This could positively impact the company's reputation and market position, potentially leading to a short-term increase in stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80